8 hours Goelzer Investment Management Inc. Decreases Stock Position in Eli Lilly and Company (NYSE:LLY)MarketBeat
2 days As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, PfizerInvestor's Business Daily
2 days Eli Lilly and Company (NYSE:LLY) Given Buy Rating at Deutsche Bank AktiengesellschaftMarketBeat
3 days Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren’t Slackers.Investor's Business Daily
3 days 718 Shares in Eli Lilly and Company (NYSE:LLY) Acquired by Passive Capital Management LLC.MarketBeat
3 days Is Eli Lilly Stock A Buy After Snagging Approval For A New Eczema Drug?Investor's Business Daily
3 days Drugmaker Lilly slates another $4.5B for manufacturing and drug development improvementsMarketBeat
4 days Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipelineYouTube
4 days Port strike fallout: Blockbuster weight-loss drug supply for U.S. hit by East Coast trade shutdownCNBC
5 days Ted Buchan & Co Makes New $1.78 Million Investment in Eli Lilly and Company (NYSE:LLY)MarketBeat
7 days 33,819 Shares in Eli Lilly and Company (NYSE:LLY) Purchased by Magnolia Capital Advisors LLCMarketBeat
1 week Jim Cramer Reports That Eli Lilly and Company (LLY)’s Donanemab Was Approved in Japan For Treating Early Symptomatic Alzheimer’s DiseaseInsider Monkey
1 week Success in This New Battleground Could Make Eli Lilly and Novo Nordisk Stock Absolutely Fly for YearsThe Motley Fool
1 week BioAge Labs, An Obesity Newcomer And Eli Lilly Partner, Rises On Upsized IPOInvestor's Business Daily